Cargando…
Rapid Onset Severe Immune Thrombocytopenia following mRNA COVID-19 Vaccine in a Young Patient
The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the world. Vaccination against COVID-19 has been approved for the following three vaccines in the United States: Pfizer-BioNTech, Moderna, and Janssen. Hematological complications of vaccination have been reporte...
Autores principales: | Avila, Jorge, Degirmenci, Huseyin Berk, Contreras Chavez, Pamela, Battinelli, Elisabeth M., Fleisher, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027455/ https://www.ncbi.nlm.nih.gov/pubmed/36950529 http://dx.doi.org/10.1155/2023/7877536 |
Ejemplares similares
-
mRNA-1273: Immune thrombocytopenia: case report
Publicado: (2021) -
Re-exposure causing rapid onset of vancomycin induced thrombocytopenia
por: Boodhai, Brent, et al.
Publicado: (2022) -
A Sudden Onset of Severe Thrombocytopenia While Using Evolocumab
por: Inoue, Ikuo, et al.
Publicado: (2020) -
mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice
por: Kim, Jae-Yong, et al.
Publicado: (2023) -
Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
por: Sato, Shintaro, et al.
Publicado: (2021)